COVID-19 Impact on Pharma: A Q1 Earnings Narrative

Aditya Kelkar

The COVID-19 outbreak generated widespread concern over how pharmaceutical, biotechnology, and medtech companies would cope with stringent national and regional lockdowns. Financial results from Q1 provide the first indicator of how this public health crisis will impact this industry and what the future may hold.  By early May, earnings for most of the significant players in the pharma industry had been announced, …